"PARP1" Related Products

Expand
Expand

Recombinant Human PARP1, His-tagged

Cat. No.: PARP1-640H
Product Overview: Recombinant Human PARP1 is produced inSf21cells and fused at the N-terminus to a His-tag.
Description: The coenzyme NAD and its derivatives are involved in hundreds of metabolic redox reactions and are utilized in protein ADP-ribosylation, histone deacetylation, and in some Ca(2+) signaling pathways. NMNAT (EC 2.7.7.1) is a central enzyme in NAD biosynthesis, catalyzing the condensation of nicotinamide mononucleotide (NMN) or nicotinic acid mononucleotide (NaMN) with the AMP moiety of ATP to form NAD or NaAD.
Source: Sf21.
Purity: ≥95% (SDS-PAGE).
Concentration: 0.5mg/ml.
Formulation: Liquid. In 50mM TRIS-HCl, pH 7.5, containing 100mM sodium chloride, 50mM imidazole, 0.2% NP-40 and 10% glycerol.
Storage And Stability: -80°C. After opening, prepare aliquots and store at -80°C. Avoid freeze/thaw cycles.
Gene Name: PARP1 poly (ADP-ribose) polymerase 1 [ Homo sapiens ]
Synonyms: PARP1; poly (ADP-ribose) polymerase 1; ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase); ADP-ribosyltransferase NAD(+); poly (ADP-ribose) polymerase family, member 1; poly(ADP-ribose) polymerase; poly(ADP-ribose) synthetase; poly(ADP-ribosyl)transferase; PARP; PPOL; ADPRT; ADPRT1; PARP-1; pADPRT-1; EC 2.4.2.30
Gene ID: 142
mRNA Refseq: NM_001618
Protein Refseq: NP_001609
MIM: 173870
UniProt ID: P09874
Chromosome Location: 1q41-q42
Pathway: Base excision repair
Function: DNA binding; NAD or NADH binding; NAD+ ADP-ribosyltransferase activity; identical protein binding; protein N-terminus binding; transcription factor binding; transferase activity, transferring glycosyl groups; zinc ion binding

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.